These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26959357)

  • 1. Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller.
    Leitman EM; Willberg CB; De Burgh-Thomas A; Streeck H; Goulder PJ; Matthews PC
    AIDS; 2016 Mar; 30(6):972-4. PubMed ID: 26959357
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.
    Tjiam MC; Morshidi MA; Sariputra L; Martin JN; Deeks SG; Tan DBA; Lee S; Fernandez S; French MA
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):e90-e92. PubMed ID: 28604502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.
    Almeida CA; van Miert P; O'Driscoll K; Zoet YM; Chopra A; Watson M; de Santis D; Witt C; John M; Claas FHJ; D'Orsogna LJ
    Cell Immunol; 2017 Jun; 316():32-40. PubMed ID: 28372798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
    Lissina A; Fastenackels S; Inglesias MC; Ladell K; McLaren JE; Briceño O; Gostick E; Papagno L; Autran B; Sauce D; Price DA; Saez-Cirion A; Appay V
    AIDS; 2014 Feb; 28(4):477-86. PubMed ID: 24384691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.
    Kløverpris HN; Stryhn A; Harndahl M; Payne R; Towers GJ; Chen F; Riddell L; Walker BD; Ndung'u T; Leslie A; Buus S; Goulder P
    J Virol; 2013 Oct; 87(19):10889-94. PubMed ID: 23864640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
    Techakriengkrai N; Tansiri Y; Hansasuta P
    AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B*14:02-Restricted Env-Specific CD8
    Leitman EM; Willberg CB; Tsai MH; Chen H; Buus S; Chen F; Riddell L; Haas D; Fellay J; Goedert JJ; Piechocka-Trocha A; Walker BD; Martin J; Deeks S; Wolinsky SM; Martinson J; Martin M; Qi Y; Sáez-Cirión A; Yang OO; Matthews PC; Carrington M; Goulder PJR
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.
    Roshorm Y; Hong JP; Kobayashi N; McMichael AJ; Volsky DJ; Potash MJ; Takiguchi M; Hanke T
    Eur J Immunol; 2009 Jul; 39(7):1831-40. PubMed ID: 19585509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
    D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
    Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
    Bansal A; Gehre MN; Qin K; Sterrett S; Ali A; Dang Y; Abraham S; Costanzo MC; Venegas LA; Tang J; Manjunath N; Brockman MA; Yang OO; Kan-Mitchell J; Goepfert PA
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.
    Berger CT; Frahm N; Price DA; Mothe B; Ghebremichael M; Hartman KL; Henry LM; Brenchley JM; Ruff LE; Venturi V; Pereyra F; Sidney J; Sette A; Douek DC; Walker BD; Kaufmann DE; Brander C
    J Virol; 2011 Sep; 85(18):9334-45. PubMed ID: 21752903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
    Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
    Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
    Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
    J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.
    Mendoza D; Royce C; Ruff LE; Ambrozak DR; Quigley MF; Dang T; Venturi V; Price DA; Douek DC; Migueles SA; Connors M
    J Virol; 2012 Apr; 86(7):4014-8. PubMed ID: 22278241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.